김은석

김은석 (chief executive) discloses dealings in 대화제약 to DART (FSS). Between 19 December 2022 and 22 September 2026, the trades on record add up to 15 filings.

Every open-market trade on record is a purchase: 14 purchases worth €83k, and no sale. The amount is not disclosed for 8 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 8 purchases and no sales.

In size, the median ticket on the buying side is €9,014. Relative to company size, the median is 0.016% of market cap (3 purchases with a known value). None of the 10 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -39.3%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 22 September 2026: an open-market purchase, in 대화제약. Typically, a trade is published a median of 15 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.